scorecardresearch
Thursday, July 24, 2025
TopicSickle cell

Topic: sickle cell

‘Genetic scissors’ — India using same tech to find sickle cell cure as gene therapy approved by US FDA

FDA-approved Casgevy & Lyfgenia made from patients’ blood stem cells which are modified and given back as single-dose infusion. India ‘in preclinical stage’ of trial of similar therapy.

Cure for sickle cell disease on the horizon? US drug regulator is reviewing 2 new gene therapies

FDA is scheduled to review gene therapies from two American companies — Vertex Pharmaceuticals & Bluebird Bio Inc. If approved, therapies could mean a breakthrough for curing SCD.

Anaemia in India has a caste angle. That’s where new Modi govt scheme can help

India has the highest prevalence of sickle cell anaemia in South Asia. The new National Sickle Cell Anaemia Elimination Program can be a trendsetter.

Sickle-cell anemia cards for all tribals below 40, screening to start from Chhattisgarh

Under the programme, all 7 crore tribals will get the identity cards which will tell if they are positive or carriers. The cards are to be matched before a marriage.

On Camera

Defence, tech, education—Modi’s visit will boost India-UK ties

Given the immediate challenges on India’s borders, cooperation in the defence sector with partners such as the UK has achieved greater importance.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Indian firm sets up titanium, superalloy plants to meet global need. Safran, Dassault, BAE line up

PTC Industries is investing Rs 1,000 cr in 4 manufacturing plants in UP, has already started supplying titanium parts to BAE Systems for its M-777 howitzers that India also uses.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.